zytiga
janssen-cilag international n.v. - abirateron asetat - blöðruhálskirtli - innkirtla meðferð - Þeir sem er fram með prednisone eða prednisólóni fyrir:meðferð sjúklingum gelding þola krabbamein í blöðruhálskirtli í fullorðnir menn sem eru einkennalaus eða dálítið einkennum eftir bilun andrógen skort meðferð í hvern lyfjameðferð er ekki enn vísindalega indicatedthe meðferð af sjúklingum gelding þola krabbamein í blöðruhálskirtli í fullorðnum körlum sem sjúkdómurinn hefur gengið á eða eftir docetaxel byggt lyfjameðferð meðferð.
abiraterone mylan
mylan ireland limited - abirateron asetat - blöðruhálskirtli - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abirateron asetat - blöðruhálskirtli - innkirtla meðferð - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - stækkun Æxli, gelding-Þola - Æxlishemjandi lyf - treatment of adult patients with prostate cancer.
kyleena leginnlegg 19.5 mg
bayer a/s* - levonorgestrelum inn - leginnlegg - 19.5 mg
jaydess leginnlegg 13,5 mg
bayer ab - levonorgestrelum inn - leginnlegg - 13,5 mg
timosan depot í stakskammtaíláti augnhlaup í stakskammtaíláti 1 mg/g
santen oy* - timololum maleat - augnhlaup í stakskammtaíláti - 1 mg/g
kabiven innrennslislyf, fleyti
fresenius kabi ab - soya-bean oil refined; glucosum; alaninum inn; arginine; aspartic acid; glutamic acid; glycine; histidinum inn; isoleucinum inn; leucinum inn; lysinum inn; methioninum inn; phenylalaninum inn; proline; serine; threoninum inn; tryptophanum inn; tyrosinum inn; valine; natrii glycerophosphas; magnesii sulfas; kalii chloridum; sodium acetate trihydrate; calcium chloride dihydrate - innrennslislyf, fleyti
gonazon
intervet international bv - azagly-nafarelin - hinsveiflur og heilahimnubólur og hliðstæður - dogs; salmonidae (salmonid fish) - kvenkyns laxfiska fisk eins og atlantic lax (salmo salar), regnboga silungur (oncorhynchus mykiss), brúnn silungur (salmo trutta) og árum síðan (salvelinus alpinus)framkalla og samstilltri egglos fyrir framleiðslu eyed-egg og steikja. hundar (tíkur)fyrirbyggja kynkirtla í tíkur í gegnum langan tíma vegartálma á gónadótrópín myndun.
renagel
sanofi b.v. - sevelamer - renal dialysis; hyperphosphatemia - Öll önnur lækningavörur - renagel is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 - dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.